On September 7, 2021 Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, reported that members of management will present at three upcoming investor conferences (Press release, Mersana Therapeutics, SEP 7, 2021, View Source [SID1234587372]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2021 Global Healthcare Conference
Format: Fireside Chat
Date/Time: Tuesday, September 14, 2021, at 8:30 a.m. ET

Morgan Stanley 19th Annual Global Healthcare Conference
Format: Fireside Chat
Date/Time: Wednesday, September 15, 2021, at 1:15 p.m. ET

2021 Cantor Virtual Global Healthcare Conference
Format: Presentation
Date/Time: Tuesday, September 28, 2021, at 4:00 p.m. ET
A live webcast of these events will be available on the Investors & Media section of Mersana’s website at www.mersana.com. An archived replay will be available for approximately 90 days following the event.